Answers are grounded in this paper and cite their sources.
Clinicians should remain careful with propofol in neonates because of the reduced clearance and extensive interindividual variability. We strongly dissuade the use of continuous or repeated intermittent administration of propofol in the first weeks of life and suggest to study the pharmacodynamics of single bolus administration of propofol in neonates.
No takes yet. Share an insight, caveat, or question.
Karel Allegaert (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: